‘We are worried for what lies ahead’ say Harrow parents in donor plea for son, 4 – My London

The parents of a four-year-old boy have been left shocked at news their son would only have months to live without receiving a stem cell transplant.

Nirav and Kirpa Gudhka, from Harrow, found out their son, Veer, had a rare blood disease in August 2019.

Veer is one of few hundred people in the UK who have the life changing illness, Fanconi Anaemia.

Doctors initially told the family it would be at least three years before Veer needed a transplant. However, recent tests have revealed his condition is getting worse faster than expected.

Nirav and Kirpa, along with Veer's sister Sahani, five, are urgently calling for stem cell donors from a South Asian background to come forward.

The entire family were tested but unfortunately none of them were a suitable match for Veer. The family has also been working with blood cancer charity, Anthony Nolan, to boost their search and give Veer the best possible chance of finding a suitable donor.

Nirav said: " We have known that he will ultimately need a transplant since he was diagnosed in August 2019, but the predictions were that he would probably hold out for a few years.

"We had hoped that would be the case, if not that, he would rebound and prove as some anomaly to the stats.

We feel so unprepared and are very worried for what lies ahead.

You can get all the latest MyLondon headlines in your email inbox by signing up here

Currently only 69 per cent of patients can find the best possible stem cell match from a stranger and this drops significantly to 20 per cent if you're a patient from a Black, Asian or ethnic minority background.

This makes it harder for Veer to find a donor who is a good match.

Since first launching the campaign to help Veer find a donor, hundreds have been inspired to join the stem cell register and in May 2020 the family hosted a virtual fundraiser for Anthony Nolan which saw total donations of just under 10,000.

Doctors are hoping to buy Veer some extra time before needing the transplant by putting him on a steroid treatment to boost his blood count but there are concerns this may not take effect.

"Hes been a real soldier through his numerous blood tests and other procedures. He definitely lives up to the meaning of his name (Veer means brave)" said Nirav.

Get more news updates for your local area by putting your postcode into our handy widget below:

He added: " As much as we dont want it to take over our lives, it has. We know that finding a donor is like finding a needle in a haystack, so we are campaigning hard."

Rebecca Sedgwick, National Recruitment Manager at Anthony Nolan, said: The tale of brave Veer has touched hearts around the country, inspiring almost 700 selfless individuals to sign up as stem cell donors. Time is now critical for Veer and his family, so were hoping that anyone thinking of joining acts right away.

To find out more about how you can help Veer by becoming a donor, click here.

Read more here:
'We are worried for what lies ahead' say Harrow parents in donor plea for son, 4 - My London

New Combination Therapy for Head and Neck Squamous Cell Carcinoma Shows Potential – Clinical OMICs News

Head and neck squamous cell carcinoma (HNSCC) develops in the mucous membranes of the mouth, nose, and throat. It is an aggressive life-threatening disease associated with high mortality rates, and accounts for more than 90% of the cancers of the head and neck.

PD1 blockade-based combination therapy has been approved as a first-line treatment for HNSCC. However, the response rate remains relatively low, and patients with HNSCC eventually relapse. Now scientists at the UCLA Jonsson Comprehensive Cancer Center and UCLA School of Dentistry have revealed a potential new combination therapy to treat advanced head and neck squamous cell carcinoma. Using a mouse model, researchers found that using an anti-PD1 immunotherapy drug in combination with PTC209, an inhibitor that targets the protein BMI1, successfully stopped the growth and spread of the cancer, prevented reoccurrences, and eliminated cancer stem cells.

Their findings, BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse, is published inCell Stem Cell.

PD1 blockade combined with chemotherapy has been approved for recurrent or metastatic head and neck cancer. However, response rates remain low and response duration is suggesting that this type of cancer might be resistant to PD1 blockade.

The researchers sought to overcome the resistance and had been studying the role of cancer stem cells and the protein BMI1. BMI1, a polycomb group (PcG) protein, plays a critical role in epigenetic regulation of cell differentiation and proliferation, and cancer stem cell self-renewal.

The researchers used a mouse model of HNSCC that mimicked human cancer development and metastasis, allowing them to perform lineage tracing of BMI1-positive cancer stem cells in an undisturbed tumor immune microenvironment. Then they tested whether BMI1 cancer stem cells could be eliminated by PD1 blockade-based combination therapy using both pharmacological and genetic inhibition of BMI1.

Here, we show that the combination treatment of anti-PD1 and cisplatin enriched BMI1+ CSCs in HNSCC while inhibiting HNSCC growth. In contrast, the pharmacological and genetic inhibition of BMI1 eliminated BMI1+ CSCs and enabled PD1 blockade therapy, resulting in the inhibition of metastatic HNSCC and prevention of HNSCC relapses, the researchers wrote.

BMI1 inhibition induced tumor cell-intrinsic immune responses by recruiting and activating CD8+T cells along with eliminating BMI1 and cancer stem cells.

This is the first preclinical study to provide evidence that targeting BMI1 proteins enhances immunotherapy and eliminates cancer stem cells by activating antitumor immunity. This discovery holds promise for those with advanced head and neck cancers who are treated with PD1 blockade, but later become resistant to therapy.

Read the original:
New Combination Therapy for Head and Neck Squamous Cell Carcinoma Shows Potential - Clinical OMICs News

Herd immunity: Is it the answer to stopping the spread of COVID-19? – 12news.com KPNX

PHOENIX Herd immunity:That isa phrase we have heard and reada lot lately in the debate over the best way to stop the spread of COVID-19.

Arizona is deep inthe coronavirus pandemic if you ask health experts. Over the last fewweeks,the number of cases in the Grand Canyon State have exploded.

Arizonans have been asked by state healthofficialsto physical distance, wear a mask and wash their handsin an effort tostem the tide of the virus.

However, there are some people that believe that is not the right approach, citing it keeps us from gaining herd immunity.

But what is herd immunity? And will it work against the coronavirus?

DeeptaBhattacharya, associate professor of immunobiology at the University of Arizona, explainedherd immunity is when a significant portion of a population is exposed to a virus and becomes immune toit.

Herd immunity is when enough people haveacquiredresistance to the infections that transmission is slowed down so that very few new infections are reported as a result,Bhattacharya said.

Bhattacharya saidherd immunityis usually achieved when about 70% of the population gains that resistance.

What we are seeing now, even in the hardest of hardest hit spots...only about 20 percent of people have been infected by the virus and show some signs of immunity to it, Bhattacharya said.

Experts say there are two ways to accomplish herd immunity: With a vaccine or naturally.

Bhattacharya said scientists are working on vaccinesthat consists of antibodies that help fight the virus,as well as,vaccines that are made upproteins that allow the human body to make its ownantibodies

The vaccines are basically proteins of the virus. It is not the actual virus but they are proteins of the virusthat you are immunized against andso thenyourownbodyis makingantibodiesagainst those proteins, so if youre ever exposed to the virus naturally youll already have thoseantibodiesthat can prevent it from getting into your cells,Bhattacharya explained.

Whilea number ofcompanies are racing to develop and test avaccine,we are still months and perhaps years from a viablecureforCOVID-19.Andsome might be wonderingwhy we did not just try to accomplish herd immunity naturally.

Doctors from the Mayo Clinic sayherd immunity can be accomplished if a virus is spreadthroughout a communitybecause people naturally develop antibodies against the virus.

Scientists say there are some issues with developing herd immunitynaturallyfor COVID-19.

For one, itis still notclear to researchers if a person who recovered from the virus can maintain immunity.

Second, research has shown some people have contracted the virus more than once.

Further research is needed to determine the protective effect of antibodies to the virus in those who have been infected,according to a Mayo Clinic report.

Nearly 230 million Americans would have to recover fromcoronavirus in order to accomplish herd immunity naturallyand stop the pandemic.

Health experts saya push for natural herd immunity couldlead to overwhelming the health care system and more people dying.

This amount of infection could also lead to serious complications and millions of deaths, especially among older people and those who have chronic conditions, a Mayor Clinic report explained.

All eyes were on Swedenearly on in thepandemicas the countrychose topursue natural herd immunity.The country of about 10 million people did not enact an official lockdown and kept schools open,according to an NBC report.

Sweden reported 78,504 cases and 5,667 deaths related to COVID-19 as of Thursday.The death rate in Sweden is much higher than that of its Nordic neighborsFinland, Norway and Denmark.

Many health experts saythe best approach to combating COVID is continuing to physical distance, wear a mask in public and wash your hands regularly.

Link:
Herd immunity: Is it the answer to stopping the spread of COVID-19? - 12news.com KPNX

FDA extends deadline for stem cell clinics to comply with …

Actual Covid-19 case count could be 6 to 24

Actual Covid-19 case count could be 6 to 24 times higher than official estimates, CDC study

Studies provide glimpse at efficacy of Covid-19 vaccines from

Studies provide glimpse at efficacy of Covid-19 vaccines from Oxford-AstraZeneca and CanSino

We dont actually have that answer yet: WHO clarifies

We dont actually have that answer yet: WHO clarifies comments on asymptomatic spread of Covid-19

Pharmalittle: U.S. to pay $1.95b for Pfizer-BioNTech Covid-19 vaccine;

Pharmalittle: U.S. to pay $1.95b for Pfizer-BioNTech Covid-19 vaccine; who decides who gets the first doses?

Among biotech venture capital firms, Flagship Pioneering got the

Among biotech venture capital firms, Flagship Pioneering got the best single-fund returns

Hospitals deploy AI to send patients home earlier

Hospitals deploy AI to send patients home earlier and keep them there

View post:
FDA extends deadline for stem cell clinics to comply with ...

Global Stem Cell Banking Market is Expected to Exhibit a CAGR of XX% During the Forecast Period (2020-2029) – Cole of Duty

Market Scenario of the Stem Cell Banking Market:

The most recent Stem Cell Banking Market Research study includes some significant activities of the current market size for the worldwide Stem Cell Banking market. It presents a point by point analysis dependent on the exhaustive research of the market elements like market size, development situation, potential opportunities, and operation landscape and trend analysis. This report centres around the Stem Cell Banking-business status, presents volume and worth, key market, product type, consumers, regions, and key players.

Market Segmentation: Global Stem Cell Banking Market

The market is based on

Request a free sample of this report with COVID-19 Impact @ https://www.regalintelligence.com/request-covid19-global-insights/151669

This research leads to comprehending the present scenario of the market, particularly in 2020. Top-down and base up approaches were utilized to estimate the total market size. This will support all the manufacturers and investors to have a superior understanding of the direction wherein the market is going.

The report will be useful in watching out for development factors, inadequacies, dangers, and the lucrative opportunities that the market will offer over the forecast time frame. The report additionally includes the revenue; industry size, share, production volume, and utilization so as to pick up insights about the legislative issues and tussle of dealing with a colossal lump of the market share.

Stem Cell Banking Market Competitive Analysis:

The Stem Cell Banking Industry is generally rewarding because of the presence of several built-up players and their steady developing marketing strategies to expand their market share. The dealers accessible in the market fixated on value, quality, brand, product differentiation, and product portfolio. The sellers are progressively stressing product customization through customer connection.

The index of the Stem Cell Banking Market report:

Access full Report Description, TOC, Table of Figure, and [emailprotected] https://www.regalintelligence.com/buyNow/151669

In the end, Stem Cell Banking Market Report conveys end which incorporates Breakdown and Data Triangulation, Consumer Needs/Customer Preference Change, Research Findings, Market Size Estimation, Data Source. These variables will expand business by and large.

Table of Contents

Chapter 1 Stem Cell Banking Market Overview 1.1 Stem Cell Banking Definition 1.2 Global Stem Cell Banking Market Size Status and Outlook (2014-2029) 1.3 Global Stem Cell Banking Market Size Comparison by Region (2014-2029) 1.4 Global Stem Cell Banking Market Size Comparison by Type (2014-2029) 1.5 Global Stem Cell Banking Market Size Comparison by Application (2014-2029) 1.6 Global Stem Cell Banking Market Size Comparison by Sales Channel (2014-2029) 1.7 Stem Cell Banking Market Dynamics (COVID-19 Impacts) 1.7.1 Market Drivers/Restraints 1.7.2 COVID-19 Impacts on Current Market 1.7.3 Post-Strategies of COVID-19 Outbreak Chapter 2 Stem Cell Banking Market Segment Analysis by Player 2.1 Global Stem Cell Banking Sales and Market Share by Player (2017-2019) 2.2 Global Stem Cell Banking Revenue and Market Share by Player (2017-2019) 2.3 Global Stem Cell Banking Average Price by Player (2017-2019) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Stem Cell Banking Market Segment Analysis by Type 3.1 Global Stem Cell Banking Market by Type 3.1.1 Umbilical Cord Blood Stem Cell 3.1.2 Embryonic Stem Cell 3.1.3 Adult Stem Cell 3.1.4 Other 3.2 Global Stem Cell Banking Sales and Market Share by Type (2014-2019) 3.3 Global Stem Cell Banking Revenue and Market Share by Type (2014-2019) 3.4 Global Stem Cell Banking Average Price by Type (2014-2019) 3.5 Leading Players of Stem Cell Banking by Type in 2019 3.6 Conclusion of Segment by Type Chapter 4 Stem Cell Banking Market Segment Analysis by Application 4.1 Global Stem Cell Banking Market by Application 4.1.1 Diseases Therapy 4.1.2 Healthcare 4.2 Global Stem Cell Banking Sales and Market Share by Application (2014-2019) 4.3 Leading Consumers of Stem Cell Banking by Application in 2019 4.4 Conclusion of Segment by Application Chapter 5 Stem Cell Banking Market Segment Analysis by Sales Channel 5.1 Global Stem Cell Banking Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Stem Cell Banking Sales and Market Share by Sales Channel (2014-2019) 5.3 Leading Distributors/Dealers of Stem Cell Banking by Sales Channel in 2019 5.4 Conclusion of Segment by Sales Channel

Much obliged to you for your time. You can likewise request individual chapter wise section or region wise report [emailprotected] https://www.regalintelligence.com/request-toc/151669

In the event that you dont find that you are looking in this report or need any particular prerequisites, please get in touch with our custom research team at [emailprotected]

Original post:
Global Stem Cell Banking Market is Expected to Exhibit a CAGR of XX% During the Forecast Period (2020-2029) - Cole of Duty

Stem Cell Cartilage Regeneration Market 2020 Size, Global Trends, Development Status, Opportunities, Comprehensive Research Study, Future Plans,…

Other

Market by Region:

Points Covered in The Report:

Key questions answered in the report:

Purchase this report (Price3660 USD for single user license) https://www.marketreportsworld.com/purchase/15917832

Stem Cell Cartilage Regeneration Market2020 global industry research report is a professional and in-depth study on the market size, growth, share, trends, as well as industry analysis. The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companys profiles, besides, market price and channel features are covered in the report. Furthermore, market size, the revenue share of each segment and its sub-segments, as well as forecast figures are also covered in this report.

Research objectives:

Years considered for this report:

Detailed TOC of Global Stem Cell Cartilage Regeneration Market Study 2020-2025

1Stem Cell Cartilage RegenerationIntroduction and Market Overview 1.1 Objectives of the Study 1.2 Overview ofStem Cell Cartilage Regeneration 1.3 Scope of The Study 1.3.1 Key Market Segments 1.3.2 Players Covered 1.3.3 COVID-19s impact on theStem Cell Cartilage Regenerationindustry 1.4 Methodology of The Study 1.5 Research Data Source

2 Executive Summary 2.1 Market Overview 2.1.1 GlobalStem Cell Cartilage RegenerationMarket Size, 2015 2020 2.1.2 GlobalStem Cell Cartilage RegenerationMarket Size by Type, 2015 2020 2.1.3 GlobalStem Cell Cartilage RegenerationMarket Size by Application, 2015 2020 2.1.4 GlobalStem Cell Cartilage RegenerationMarket Size by Region, 2015 2025 2.2 Business Environment Analysis 2.2.1 Global COVID-19 Status and Economic Overview 2.2.2 Influence of COVID-19 Outbreak onStem Cell Cartilage RegenerationIndustry Development

3 Industry Chain Analysis 3.1 Upstream Raw Material Suppliers ofStem Cell Cartilage RegenerationAnalysis 3.2 Major Players ofStem Cell Cartilage Regeneration 3.3Stem Cell Cartilage RegenerationManufacturing Cost Structure Analysis 3.3.1 Production Process Analysis 3.3.2 Manufacturing Cost Structure ofStem Cell Cartilage Regeneration 3.3.3 Labor Cost ofStem Cell Cartilage Regeneration 3.4 Market Distributors ofStem Cell Cartilage Regeneration 3.5 Major Downstream Buyers ofStem Cell Cartilage RegenerationAnalysis 3.6 The Impact of Covid-19 From the Perspective of Industry Chain 3.7 Regional Import and Export Controls Will Exist for a Long Time 3.8 Continued downward PMI Spreads Globally

4 GlobalStem Cell Cartilage RegenerationMarket, by Type 4.1 GlobalStem Cell Cartilage RegenerationValue and Market Share by Type (2015-2020) 4.2 GlobalStem Cell Cartilage RegenerationProduction and Market Share by Type (2015-2020) 4.3 GlobalStem Cell Cartilage RegenerationValue and Growth Rate by Type (2015-2020) 4.3.1 GlobalStem Cell Cartilage RegenerationValue and Growth Rate of Rack and Pinion 4.4 GlobalStem Cell Cartilage RegenerationPrice Analysis by Type (2015-2020)

5Stem Cell Cartilage RegenerationMarket, by Application 5.1 Downstream Market Overview 5.2 GlobalStem Cell Cartilage RegenerationConsumption and Market Share by Application (2015-2020) 5.3 GlobalStem Cell Cartilage RegenerationConsumption and Growth Rate by Application (2015-2020) 5.3.1 GlobalStem Cell Cartilage RegenerationConsumption and Growth Rate of Automative (2015-2020) 5.3.2 GlobalStem Cell Cartilage RegenerationConsumption and Growth Rate of Mining (2015-2020) 5.3.3 GlobalStem Cell Cartilage RegenerationConsumption and Growth Rate of Oil & Gas (2015-2020) 5.3.4 GlobalStem Cell Cartilage RegenerationConsumption and Growth Rate of Other (2015-2020)

6 GlobalStem Cell Cartilage RegenerationMarket Analysis by Regions 6.1 GlobalStem Cell Cartilage RegenerationSales, Revenue and Market Share by Regions 6.1.1 GlobalStem Cell Cartilage RegenerationSales by Regions (2015-2020) 6.1.2 GlobalStem Cell Cartilage RegenerationRevenue by Regions (2015-2020) 6.2 North AmericaStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020) 6.3 EuropeStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020) 6.4 Asia-PacificStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020) 6.5 Middle East and AfricaStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020) 6.6 South AmericaStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020)

7 North AmericaStem Cell Cartilage RegenerationMarket Analysis by Countries 7.1 The Influence of COVID-19 on North America Market 7.2 North AmericaStem Cell Cartilage RegenerationSales, Revenue and Market Share by Countries 7.2.1 North AmericaStem Cell Cartilage RegenerationSales by Countries (2015-2020) 7.2.2 North AmericaStem Cell Cartilage RegenerationRevenue by Countries (2015-2020) 7.3 United StatesStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020) 7.4 CanadaStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020) 7.5 MexicoStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020)

8 EuropeStem Cell Cartilage RegenerationMarket Analysis by Countries 8.1 The Influence of COVID-19 on Europe Market 8.2 EuropeStem Cell Cartilage RegenerationSales, Revenue and Market Share by Countries 8.2.1 EuropeStem Cell Cartilage RegenerationSales by Countries (2015-2020) 8.2.2 EuropeStem Cell Cartilage RegenerationRevenue by Countries (2015-2020) 8.3 GermanyStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020) 8.4 UKStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020) 8.5 FranceStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020) 8.6 ItalyStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020) 8.7 SpainStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020) 8.8 RussiaStem Cell Cartilage RegenerationSales and Growth Rate (2015-2020)

Continued

Request Complete Table Of Contents Of this Report https://www.marketreportsworld.com/TOC/15917832#TOC

At last, the report gives the inside and out examination of Stem Cell Cartilage Regeneration Market took after by above components, which are useful for organizations or individual for development of their present business or the individuals who are hoping to enter in Stem Cell Cartilage Regeneration industry.

Contact Info:

Name: Ajay More

Email: [emailprotected]

Phone: US +14242530807/ UK +44 203 239 8187

Our other reports:

Graphics Display Controllers Market Size 2020 Business Revenue, Future Growth, Trends Plans, Top Key Players, Business Opportunities, Industry Share, Global Analysis by Forecast to 2025 Says, Market Reports World

Snow Chain Market Share, Size 2020 Global Industry Analysis, Key Growth Drivers Trends, Segments, Emerging Technologies, Opportunity and Forecast to 2026 Says, Market Reports World

Lithium Cobalt Oxide Market Size 2020 Global Industry Key Strategies, Share, Growth, Trends, Historical Analysis, Segmentation, Application, Technology and Opportunities Forecast to 2025

Coded Lock Market Size 2020 Global Industry Share, Growth, Trends, Statistics, Competition Strategies, Revenue Analysis, Key Players, Regional Analysis by Forecast to 2026

Radish Seeds Market Size, Share 2020 Global Industry Analysis by Trends, Company Overview, Market Demand, Technology Progress, Growth and Forecast by 2025 Latest Research Report by Market Reports World

Mining Lubricant Market Size 2020 Industry Share, Global Major Companies Profile, Growth, Competitive Landscape and Key Regions 2026 Says, Market Reports World

Laser Diode Market Size and Share 2020 Emerging Technologies, Sales Revenue, Key Players Analysis, Growth, Development Status, Opportunity Assessment and Industry Expansion Strategies 2025

Diabetes Drug Market Size 2020 Global Industry Share, Demand, Market Demand, Top Players, Future Growth by 2026 Latest Research Report by Market Reports World

Micro-Hybrid Vehicles Market Size 2020 Global Share, Business Growth, Trend, Segmentation, Top Key Players Analysis, Industry Expansion, Opportunities, Challenges, Opportunities Forecast to 2025

Stand Mixers Market Size 2020 Business Revenue, Future Growth, Trends Plans, Top Key Players, Business Opportunities, Industry Share, Global Analysis by Forecast to 2025 Says, Market Reports World

Original post:
Stem Cell Cartilage Regeneration Market 2020 Size, Global Trends, Development Status, Opportunities, Comprehensive Research Study, Future Plans,...

A brief history of racism in healthcare – World Economic Forum

If youre Black or Latino in the US, youre almost twice as likely to die from COVID-19.

Thats according to The New York Times analysis of data from Americas Centers for Disease Control and Prevention (CDC). The numbers also reveal that Native Americans are more likely to be hospitalized with the condition than other ethnic groups.

In the UK, its a similar story. Official figures show that Black people are 1.9 times more likely to die from COVID-19 than white people. In France, infection rate data is not collected by ethnicity but the trends are believed by some medical experts to be similar.

These patterns are drawing attention to long-standing health inequalities faced by ethnic minority groups. From HIV/AIDS and cancer to prenatal care, and even amputations, research shows Black, indigenous and people of colour (BIPOC) in America and elsewhere are more likely to be affected, and less likely to receive the right treatment.

Implicit bias when people are unconsciously influenced by prejudices or stereotypes can play a part in these inequalities. In the US, for example, only 4% of doctors are Black, compared to 13% of the population. Several studies show that doctors can hold negative stereotypes of BIPOC patients without realizing, which can make interactions unpleasant and affect the treatment given.

And in some cases, these inequalities stem from structural or overt racism that goes back decades, or centuries. Heres how its developed.

Spirometers measure lung capacity. In the past their readings were used to justify discrimination based on racial difference.

Image: REUTERS/Rick Wilking

Throughout history, medical racism has often been based on the myth that Black people have different and inferior bodies.

Tales of experiments that were done to show it make for grim reading.

Phrenology was one example of this the belief popular in 19th-century Europe and America that character traits could be read through differently shaped skulls. The idea that Black people were naturally submissive was used by some slave owners to justify their trade.

In America, black and Latino communities have suffered from higher coronavirus death rates than white groups.

Image: NY Times

The spirometer, a common medical device in use around the world today, also tells a story of racial difference. It measures lung capacity, and was used during the American Civil War to study the bodies of Union soldiers. Doctors incorrectly concluded Black soldiers had inferior bodies because white soldiers had a higher lung capacity.

Even today, spirometers are usually race corrected. Researchers say that history shows this practice could represent an implicit bias, discrimination, and racism, and masks economic and environmental factors.

The 'Tuskegee Study of Untreated Syphilis in the Negro Male' used 600 Black men.

Image: CDC

Deception and misinformation

Black people were used unwittingly in early 20th-century medical experiments. One of the worst examples is the Tuskegee study.

In 1932, US government researchers recruited 600 poor Black men in Alabama for a syphilis study. Free Blood Test; Free Treatment said the advert. Except the 399 in the group who had syphilis were never treated they were just observed until they died. But neither they, nor their families, were ever told about this.

The COVID-19 pandemic and recent social and political unrest have created a profound sense of urgency for companies to actively work to tackle racial injustice and inequality. In response, the Forum's Platform for Shaping the Future of the New Economy and Society has established a high-level community of Chief Diversity and Inclusion Officers. The community will develop a vision, strategies and tools to proactively embed equity into the post-pandemic recovery and shape long-term inclusive change in our economies and societies.

As businesses emerge from the COVID-19 crisis, they have a unique opportunity to ensure that equity, inclusion and justice define the "new normal" and tackle exclusion, bias and discrimination related to race, gender, ability, sexual orientation and all other forms of human diversity. It is increasingly clear that new workplace technologies and practices can be leveraged to significantly improve diversity, equity and inclusion outcomes.

The World Economic Forum has developed a Diversity, Equity and Inclusion Toolkit, to outline the practical opportunities that this new technology represents for diversity, equity and inclusion efforts, while describing the challenges that come with it.

The toolkit explores how technology can help reduce bias from recruitment processes, diversify talent pools and benchmark diversity and inclusion across organisations. The toolkit also cites research that suggests well-managed diverse teams significantly outperform homogenous ones over time, across profitability, innovation, decision-making and employee engagement.

The Diversity, Equity, and Inclusion Toolkit is available here.

The injustice had a long history: it wasnt until 1972, when the study was exposed, that it was finally shut down.

American history provides another famous example of experimentation without consent.

In 1951, Henrietta Lacks, a 30-year-old African American woman, was diagnosed in hospital with an aggressive form of cervical cancer. She was killed by the disease, but the cancer cells lived on.

They were cultured on a mass scale, becoming known as the HeLa cell line. These immortal cells were critical to medical breakthroughs, including the polio vaccine, cancer treatments and IVF. They have even been into space and you can still buy them today.

But they were taken without her, or her familys, knowledge or consent. So was this medical racism?

On one hand, the 1950s was a time when it was common not to ask family members for their consent, whatever their race. But that wasnt the only occasion. In the 1970s, when scientists went back to her children to do research on them that's the moment I think race played a significant role, Lacks biographer, Rebecca Skloot, tells National Geographic.

In 20th-century history, one of the big trends in medicine globally has been the use of computers to manage healthcare. But medical software can be racist.

In 2019, an algorithm that helps manage healthcare for 200 million people in the US was found to systematically discriminate against Black people. According to research published in the journal Science, people who self-identified as Black were given lower risk scores by the computer than white counterparts, leading to fewer referrals for medical care.

The computer appeared to give fewer referrals to Black people because their care costs on average were less over a year than for white patients (despite the Black patients being sicker).

That might be because Black people have lower levels of trust in health-care systems, an example of systemic racism where whole systems are loaded against particular groups, unknowingly or not. The researchers also suggested that direct racial discrimination by healthcare providers could play a part.

In recent years, systematic discrimination has become better understood as a powerful force around the world that traps people on lower incomes in unhealthier places - for example, in more polluted neighbourhoods, breathing dirtier air.

Yet clearly, as COVID-19 shows, systemic racism and other forms of discrimination continue to be powerful, and deadly.

Read the rest here:
A brief history of racism in healthcare - World Economic Forum

Robot That Prints New Skin Could Revolutionise Burns Treatment – PR Web

The Inventia Skin team leading the skin regeneration revolution.

SYDNEY (PRWEB) July 23, 2020

A team including fast-growing Sydney start-up Inventia Life Science, world renowned skin surgeon and former Australian of the Year, Professor Fiona Wood, and leading bioprinting researcher, Professor Gordon Wallace, have received two major investments from the Australian Government to accelerate the development of a robotic device that prints a patients own skin cells directly onto a burn or wound.

The device, codenamed Lig from the Latin to bind, could revolutionise the way we approach wound repair, and place Australia at the forefront of the burgeoning regenerative medicine industry.

Federal Health Minister Hon. Greg Hunt announced that the Governments BioMedTech Horizons program, operated by MTPConnect, will inject funding to take the device into first-in-human clinical trials within two years. Separately, the team also received funding from the Medical Research Future Fund Stem Cell Therapies Mission to collaborate with stem cell expert Professor Pritinder Kaur from Curtin University, to use the Lig device to deliver stem cell based products that could improve skin regeneration.

The skin, our bodys largest organ, is the first point of injury in accidents and some diseases. Damage it significantly and it will slowly heal and most likely leave a scar. However, throughout this process it will be open to infection while it tries to regenerate - a major problem in the bodys first protective barrier.

Inventia Skins Lig robot prints tiny droplets containing the patients skin cells and biomaterials to speed up the regenerative process and create a new layer of skin where it has been damaged. The device uses patented technology developed in Australia by parent company Inventia Life Science and featured in its RASTRUM platform for lab-based medical research and drug discovery. In taking this core technology into the clinic in the Lig robot, Inventia Skin is breaking new ground with some of Australia's leaders in skin regeneration.

When we started Inventia Life Science, our vision was to create a technology platform with the potential to bring enormous benefit to human health. We are pleased to see how fast that vision is progressing alongside our fantastic collaborators. This Federal Government support will definitely help us accelerate even faster, says Dr. Julio Ribeiro, CEO and co-founder of Inventia.

The technology within Lig enables the rapid and precise delivery of multiple cell types and advanced biomaterials to a wound, providing the potential to recreate functional and aesthetically normal skin. This can be achieved in a single procedure, reducing treatment cost and hospital stays, and minimising the risk of infection.

For one of its partners - Professor Fiona Wood, Director of Western Australias Burns Service - it's not the first time that she has looked towards bioengineering to help her patients. Professor Wood pioneered the now clinically approved spray-on skin technique to treat skin burns based on research beginning in 1993, and came to notice in 2002 at the time of the Bali Bombings. Combined with the expertise of Professor Gordon Wallace at the University of Wollongong, one of Australias most eminent researchers in bioprinting and biomaterials, Inventia Skin has a very bright future ahead.

The combination of these grants is an excellent example of the way the Medical Research Future Fund is being applied across the continuum of translational research to commercialisation, leading to better patient outcomes, says Professor Fiona Wood.

Learn more: Further information on the BioMedTech Horizons Program is available here: https://www.health.gov.au/ministers/the-hon-greg-hunt-mp/media/188-million-to-supercharge-digital-health-technologies

Contact Inventia Skin at info@inventiaskin.com Twitter or LinkedIn @InventiaSkin Australia: 1800 849 128 USA: +1 833 462 5959 Ireland: +353 818 370 035

Share article on social media or email:

Link:
Robot That Prints New Skin Could Revolutionise Burns Treatment - PR Web

Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to…

About The Author Market Study Report

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives. [emailprotected] | https://twitter.com/MarketStudyR/

Read more from the original source:
Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to...

Global Cancer Stem Cell Therapy Market 2020 | Industry Future Growth, Key Player Analysis and Forecast 2025 – Owned

This report additionally covers the effect of COVID-19 on the worldwide market. The pandemic brought about by Coronavirus (COVID-19) has influenced each part of life all inclusive, including the business segment. This has brought along a several changes in economic situations.

An Up to Date Report on Cancer Stem Cell Therapy Market size | Industry Segment by Applications, by Type, Regional Outlook, Market Demand, Latest Trends, Cancer Stem Cell Therapy Industry Share & Revenue by Manufacturers, Company Profiles, Growth Forecasts 2025. Analyzes current market size and upcoming 5 years growth of this industry. Research report on global Cancer Stem Cell Therapy market 2020 with industry primary research, secondary research, product research, size, trends and Forecast.

The new report offers a powerful combination of latest, in-depth research studies on the Cancer Stem Cell Therapy market. The authors of the report are highly experienced analysts and possess deep market knowledge.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures): http://marketresearchbazaar.com/requestSample/15380

Major Players Analyzed Under This Report are:

> AVIVA BioSciences AdnaGen Advanced Cell Diagnostics Silicon Biosystems

Cancer Stem Cell Therapy Players/Suppliers Profiles and Sales Data: Company, Company Basic Information, Manufacturing Base and Competitors, Product Category, Application and Specification with Sales, Revenue, Price and Gross Margin, Main Business/Business Overview.

Table Of Content

Market Overview: Scope & Product Overview, Classification of Cancer Stem Cell Therapy by Product Category (Market Size (Sales), Market Share Comparison by Type (Product Category)), Cancer Stem Cell Therapy Market by Application/End Users (Sales (Volume) and Market Share Comparison by Application), Market by Region (Market Size (Value) Comparison by Region, Status and Prospect Cancer Stem Cell Therapy Market by Manufacturing Cost Analysis:Key Raw Materials Analysis, Price Trend of Key Raw Materials, Key Suppliers of Raw Materials, Market Concentration Rate of Raw Materials, Proportion of Manufacturing Cost Structure (Raw Materials, Labor Cost), Manufacturing Process Analysis

Key Benefits for Stakeholders

The study provides an in-depth analysis of the Cancer Stem Cell Therapy market size along with the current trends and future estimations to elucidate the imminent investment pockets. Information about key drivers, restraints, and opportunities and their impact analysis on the market size is provided. Porters five forces analysis illustrates the potency of buyers and suppliers operating in the portable gaming industry. The quantitative analysis of the Cancer Stem Cell Therapy industry from 2020 to 2026 is provided to determine the Cancer Stem Cell Therapy market potential.

Cancer Stem Cell Therapy Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during 2020-2026

The research report is broken down into chapters, which are introduced by the executive summary. Its the introductory part of the chapter, which includes details about global market figures, both historical and estimates. The executive summary also provides a brief about the segments and the reasons for the progress or decline during the forecast period. The insightful research report on the Cancer Stem Cell Therapy market includes Porters five forces analysis and SWOT analysis to understand the factors impacting consumer and supplier behavior.

Get Customized Report in your Inbox within 24 hours: http://marketresearchbazaar.com/enquiry/15380

Market Segment Analysis

The research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type Autologous Stem Cell Transplants Allogeneic Stem Cell Transplants Syngeneic Stem Cell Transplants Others

Segment by Application Hospital Clinic Medical Research Institution Others

Cancer Stem Cell Therapy Market: Competitive Landscape

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.

Cancer Stem Cell Therapy Market: Regional Analysis

The report offers in-depth assessment of the growth and other aspects of the Cancer Stem Cell Therapy market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2025. These analyses will help the reader to understand the potential worth of investment in a particular region.

Key Strategic Developments:The study also includes the key strategic developments of the Cancer Stem Cell Therapymarket, comprising R&D, new product launch, M&A, agreements, collaborations, partnerships, joint ventures, and regional growth of the leading competitors operating in the market on a global and regional scale.

Key Market Features:The report evaluated key market features, including revenue, price, capacity, capacity utilization rate, gross, production, production rate, consumption, market share, CAGR, and gross margin. Analytical Tools: The Cancer Stem Cell Therapy Market report includes the precisely studied and weighed data of the key industry players and their scope in the Cancer Stem Cell Therapy market by means of several analytical tools

Read More Report: http://marketresearchbazaar.com/requestSample/15380

About (Market Research Bazaar):

Market Research Bazaar (MRB)- a part of VRRB Reports LLP is an overall Market Research and consulting organization. We give unparalleled nature of offering to our clients present all around the world crosswise over industry verticals. Market Research Bazaar has aptitude in giving profound jump showcase understanding alongside advertise knowledge to our clients spread across over different endeavours.

Media Contact:

Market Research Bazaar

UK: +442070973908

US: +13156360953

India: +919548234540

Email: [emailprotected]

Website: http://marketresearchbazaar.com/

Blog: http://marketresearchbazaar.com/blogs

Excerpt from:
Global Cancer Stem Cell Therapy Market 2020 | Industry Future Growth, Key Player Analysis and Forecast 2025 - Owned